FCPA Compliance Strategies for Medical Device & Pharma Companies

The Foreign Corrupt Practices Act (FCPA) has had a major impact on the way companies conduct business abroad. A U.S. anti-corruption law jointly enforced by the Department of Justice and the Securities and Exchange Commission, its main provisions deal with improper payments to foreign officials and questionable accounting practices used to hide them. Violating the FCPA can result in both criminal and civil penalties, and the requirements are complex, applying to both companies in the U.S. and foreign-based companies subject to U.S. securities laws. Past enforcement actions have crossed industry boundaries and included the pharmaceutical industry. Lately, there has been an increase in FCPA enforcement activity in the medical device industry as well.

In this audio conference, our speakers combine their experience with real-world case studies to provide a clear background on the FCPA requirements and enforcement trends, along with practical compliance strategies to keep device and pharma companies from running afoul of the law.

FCPA Compliance Strategies for Medical Device & Pharma Companies is being presented by Bethany Hills & Michelle Merola, with Hodgson Russ LLP and airs Wednesday, April 1, 2009. For more details or to register for this event, please visit our site www.fxconferences.com

The Foreign Corrupt Practices Act: Compliance Strategies

The Foreign Corrupt Practices Act (FCPA) is a U.S. anti-corruption law jointly enforced by the Department of Justice and the Securities and Exchange Commission. Its main provisions deal with improper payments to foreign offficials and questionable accounting practices to cover up these sorts of transactions. Violating FCPA requirements can result in criminal and civil penalties, and the law has had a major impact on the way companies conduct business abroad. The requirements of the FCPA are complex and apply to both companies in the U.S. and foreign-based companies subject to U.S. securities laws. Past enforcement actions have crossed industry boundaries and included the oil industry, telecommunications and pharmaceuticals. Recently, an increase in FCPA enforcement activity in the medical device industry has caught the attention of CEOs, CFOs, and Marketing and Sales executives.

In this audio conference, our speakers will combine their experience with real-world case studies to provide a clear background on the FCPA requirements and enforcement trends, along with practical compliance strategies to avoid prosecution.

The Foreign Corrupt Practices Act: Compliance Strategies is presented by Bethany Gilbert & Michelle Merola, of Hodgson Russ LLP. For more details please visit our site www.fxconferences.com